NVS - Voyager shares surge on $1.2B licensing deal with Novartis for Huntington's candidate
2024-01-02 07:14:42 ET
More on Novartis, Voyager Therapeutics, etc.
- Novartis: Post Investor Day, Higher Guidance Priced In
- Voyager Therapeutics' Strategic Partnerships And TRACER Technology - Speculative Buy
- Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript)
- Novartis wins FDA nod for rare blood disorder drug
- Blackstone said to explore sale of Anthos, developer of blood thinners
For further details see:
Voyager shares surge on $1.2B licensing deal with Novartis for Huntington's candidate